Preparation and characterization of dexamethasone polymeric nanoparticle by membrane emulsification method
Source abstract
Abstract
The objective of this study was to prepare and characterize dexamethasone polymeric nanoparticles by membrane emulsification method. Shirasu porous glass was used as a membrane for the emulsification process. The mean particle size was determined by photon correlation spectroscopy, and the drug release test was performed in the dialysis cell. The size of nanoparticles was increased with increasing applied pressure, membrane pore size, the polymeric content of the oily phase, and oil/aqueous phase ratio and replacing chloroform with dichloromethane. As ethanol content in the organic solvent increased (0, 2.5, and 5% w/w), dexamethasone solubility was increased (0.35, 3.5, and 6.4 mg/g, respectively) with a minimal effect on the particle size. The agitation speed of 800 rpm is needed to ensure the oil phase-membrane detachment. Encapsulation efficiency was higher, and the drug release was faster from Eudragit® RL and RS nanoparticles than ethylcellulose nanoparticles. For polymeric nanoparticles, size differences have no impact on the drug release. It is concluded that the particle size could be controlled by an organic solvent and polymer type in addition to process parameters in the membrane emulsification technique. Additionally, zero-order release kinetic could be achieved from polymeric nanoparticles.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Advanced Drug Delivery Systems · Innovative Microfluidic and Catalytic Techniques Innovation · Advancements in Transdermal Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (37)
Show source-provided references
1. Abdel-Mottaleb MMA, Neumann D, Lamprecht A (2011) Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers. Eur J Pharm Biopharm 79:36–4210.1016/j.ejpb.2011.04.009 ↗
2. Abdel-Mottaleb MMA, Moulari B, Beduneau A, Pellequer Y, Lamprecht A (2012) Nanoparticles enhance therapeutic outcome in inflamed skin therapy. Eur J Pharm Biopharm 82:151–15710.1016/j.ejpb.2012.06.006 ↗
3. Al-Maaieh A, Flanagan DR (2001) Salt and cosolvent effects on ionic drug loading into microspheres using an O/W method. J Control Release 70:169–18110.1016/S0168-3659(00)00347-3 ↗
4. Balzus B, Sahle FF, Hönzke S, Gerecke C, Schumacher F, Hedtrich S, Kleuser B, Bodmeier R (2017) Formulation and ex vivo evaluation of polymeric nanoparticles for controlled delivery of corticosteroids to the skin and the corneal epithelium. Eur J Pharm Biopharm 115:122–13010.1016/j.ejpb.2017.02.001 ↗
5. Charcosset C, El-Harati A, Fessi H (2005) Preparation of solid lipid nanoparticles using a membrane contactor. J Control Release 108:112–12010.1016/j.jconrel.2005.07.023 ↗
6. Graves RA, Freeman T, Pamajula S, Praetorius N, Moiseyev R, Mandal TK (2006) Effect of co-solvents on the characteristics of enkephalin microcapsules. J Biomater Sci Polym Ed 17:709–72010.1163/156856206777346296 ↗
7. Hwang T, Park T-J, Koh W-G, Cheong IW, Choi SW, Kim JH (2011) Fabrication of nano-scale liposomes containing doxorubicin using Shirasu porous glass membrane. Colloids Surf A Physicochem Eng Asp 392:250–25510.1016/j.colsurfa.2011.09.063 ↗
8. Joscelyne SM, Trägårdh G (2000) Membrane emulsification — a literature review. J Membr Sci 169:107–11710.1016/S0376-7388(99)00334-8 ↗
9. Kamble P, Sadarani B, Majumdar A, Bhullar S (2017) Nanofiber based drug delivery systems for skin: a promising therapeutic approach. J Drug Deliv Sci Technol 41:124–13310.1016/j.jddst.2017.07.003 ↗
10. Khayata N, Abdelwahed W, Chehna MF, Charcosset C, Fessi H (2012) Preparation of vitamin E loaded nanocapsules by the nanoprecipitation method: from laboratory scale to large scale using a membrane contactor. Int J Pharm 423:419–42710.1016/j.ijpharm.2011.12.016 ↗
11. Küchler S, Radowski MR, Blaschke T, Dathe M, Plendl J, Haag R, Schäfer-Korting M, Kramer KD (2009) Nanoparticles for skin penetration enhancement – a comparison of a dendritic core-multishell-nanotransporter and solid lipid nanoparticles. Eur J Pharm Biopharm 71:243–25010.1016/j.ejpb.2008.08.019 ↗
12. Kukizaki M, Nakashima T (2004) Acid leaching process in the preparation of porous glass membranes from phase-separated glass in the Na2O-CaO-MgO-Al2O3-B2O3-SiO2 system. Membrane 29:301–30810.5360/membrane.29.301 ↗
13. Liu W, Yang X-L, Winston Ho WS (2011) Preparation of uniform-sized multiple emulsions and micro/nano particulates for drug delivery by membrane emulsification. J Pharm Sci 100:75–9310.1002/jps.22272 ↗
14. Ma G (2003) Control of polymer particle size using porous glass membrane emulsification: a review. China Particuology 1:105–11410.1016/S1672-2515(07)60120-1 ↗
15. Marro D, Guy RH, Delgado-Charro MB (2001) Characterization of the iontophoretic permselectivity properties of human and pig skin. J Control Release 70:213–21710.1016/S0168-3659(00)00350-3 ↗
16. Muhaimin, Bodmeier R (2017) Effect of solvent type on preparation of ethyl cellulose microparticles by solvent evaporation method with double emulsion system using focused beam reflectance measurement. Polym Int 66:1448–145510.1002/pi.5436 ↗
17. Nakashima T, Shimizu M, Kukizaki M (1992) Membrane emulsification by microporous glass. Key Eng Mater 61–62:513–51610.4028/www.scientific.net/KEM.61-62.513 ↗
18. Oh DH, Balakrishnan P, Oh Y-K, Kim DD, Yong CS, Choi HG (2011) Effect of process parameters on nanoemulsion droplet size and distribution in SPG membrane emulsification. Int J Pharm 404:191–19710.1016/j.ijpharm.2010.10.045 ↗
19. Pathak M (2011) Numerical simulation of membrane emulsification: effect of flow properties in the transition from dripping to jetting. J Membr Sci 382:166–17610.1016/j.memsci.2011.08.005 ↗
20. Patra CN, Priya R, Swain S, Kumar Jena G, Panigrahi KC, Ghose D (2017) Pharmaceutical significance of Eudragit: a review. Futur J Pharm Sci 3:33–4510.1016/j.fjps.2017.02.001 ↗
21. Polli JE, Rekhi GS, Augsburger LL, Shah VP (1997) Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets. J Pharm Sci 86:690–70010.1021/js960473x ↗
22. Rao JP, Geckeler KE (2011) Polymer nanoparticles: preparation techniques and size-control parameters. Prog Polym Sci 36:887–91310.1016/j.progpolymsci.2011.01.001 ↗
23. Rawat A, Burgess DJ (2010) Effect of ethanol as a processing co-solvent on the PLGA microsphere characteristics. Int J Pharm 394:99–10510.1016/j.ijpharm.2010.05.013 ↗
24. Rekhi GS, Jambhekar SS (1995) Ethylcellulose-polymer review. Drug Dev Ind Pharm 21:61–7710.3109/03639049509048096 ↗
25. Rekhi GS, Jambhekar SS (2008) Ethylcellulose - a polymer review. Drug Dev Ind Pharm 21(1):61–77. https://doi.org/10.3109/0363904950904809610.3109/03639049509048096 ↗
26. Romero A, Cordobés F, Puppo MC, Guerrero A, Bengoechea C (2008) Rheology and droplet size distribution of emulsions stabilized by crayfish flour. Food Hydrocoll 22:1033–104310.1016/j.foodhyd.2007.05.019 ↗
27. Sahle FF, Balzus B, Gerecke C, Kleuser B, Bodmeier R (2016) Formulation and in vitro evaluation of polymeric enteric nanoparticles as dermal carriers with pH-dependent targeting potential. Eur J Pharm Sci 92:98–10910.1016/j.ejps.2016.07.004 ↗
28. Schäfer-Korting M, Mehnert W, Korting H-C (2007) Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Rev 59:427–44310.1016/j.addr.2007.04.006 ↗
29. Schoepe S, Schacke H, May E, Asadullah K (2006) Glucocorticoid therapy-induced skin atrophy. Exp Dermatol 15:406–42010.1111/j.0906-6705.2006.00435.x ↗
30. Shakeel F, Baboota S, Ahuja A, Ali J, Aqil M, Shafiq S (2007) Nanoemulsions as vehicles for transdermal delivery of aceclofenac. AAPS PharmSciTech 8:191–19910.1208/pt0804104 ↗
31. Spyropoulos F, Lloyd DM, Hancocks RD, Pawlik AK (2014) Advances in membrane emulsification. Part B: recent developments in modelling and scale-up approaches. J Sci Food Agric 94:628–63810.1002/jsfa.6443 ↗
32. Thakral S, Thakral NK, Majumdar DK (2013) Eudragit®: a technology evaluation. Expert Opin Drug Deliv 10:131–14910.1517/17425247.2013.736962 ↗
33. Vanderhoff JW, El-Aasser MS, Ugelstad J (1979) Polymer emulsification process
34. Verma DD, Verma S, Blume G, Fahr A (2003) Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm 258:141–15110.1016/S0378-5173(03)00183-2 ↗
35. Wei Y, Wang Y, Wang L, Hao D, Ma G (2011) Fabrication strategy for amphiphilic microcapsules with narrow size distribution by premix membrane emulsification. Colloids Surf B: Biointerfaces 87:399–40810.1016/j.colsurfb.2011.05.051 ↗
36. Yu Y, Tan S, Zhao S et al (2013) Antitumor activity of docetaxel-loaded polymeric nanoparticles fabricated by Shirasu porous glass membrane-emulsification technique. Int J Nanomedicine 8:2641–2652. https://doi.org/10.2147/IJN.S4821410.2147/IJN.S48214 ↗
37. Zweers MLT, Grijpma DW, Engbers GHM, Feijen J (2003) The preparation of monodisperse biodegradable polyester nanoparticles with a controlled size. J Biomed Mater Res 66B:559–56610.1002/jbm.b.10046 ↗